IDL Biotech AB (XSAT:IDL) Marketable Securities : kr0.00 Mil (As of Jun. 2021)

View and export this data going back to 2004. Start your Free Trial

What is IDL Biotech AB Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. IDL Biotech AB's Marketable Securities for the quarter that ended in Jun. 2021 was kr0.00 Mil.

IDL Biotech AB Marketable Securities Historical Data

The historical data trend for IDL Biotech AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDL Biotech AB Marketable Securities Chart

IDL Biotech AB Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Marketable Securities

Get a 7-Day Free Trial

IDL Biotech AB Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

IDL Biotech AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

IDL Biotech AB (XSAT:IDL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

IDL Biotech AB Marketable Securities Related Terms

Thank you for viewing the detailed overview of IDL Biotech AB's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

IDL Biotech AB (XSAT:IDL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDL Biotech AB (XSAT:IDL) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Karlsbodavagen 39, Stockholm, SWE

Website

http://www.idl.se

IDL Biotech AB develops, produces and markets In Vitro Diagnostic tests for the health care sector. It offers in vitro diagnostic tests within the clinical areas of oncology and bacteriology. The company's trademark products includes TUBEX, TPS, UBC, MonoTotal and TPAcyk.

IDL Biotech AB (XSAT:IDL) Headlines

No Headlines